Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

Group 1: Company Announcement - Nutriband Inc. has signed an exclusive distribution agreement with Costa Rica-based Innomedica for the AVERSA Fentanyl product and all sports tape products manufactured at its Pocono Pharmaceutical / Active Intell subsidiary [1] - Innomedica will oversee and finance all regulatory approvals for the mentioned products as they prepare for launch [1] Group 2: AVERSA Technology - AVERSA™ is an abuse-deterrent transdermal technology that incorporates aversive agents into patches to prevent drug abuse, diversion, misuse, and accidental exposure [2] - The technology aims to enhance the safety profile of transdermal drugs, particularly opioids and stimulants, while ensuring accessibility for patients in need [2] - AVERSA™ technology is protected by a broad intellectual property portfolio with patents granted in multiple countries including the United States, Europe, Japan, and China [2] Group 3: Company Overview - Nutriband Inc. focuses on developing a portfolio of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch utilizing AVERSA™ technology [3] - The AVERSA™ technology can be integrated into any transdermal patch to mitigate the risks of drug abuse and misuse [3]